Surgeons experiences

by David Allamby, MD, Jeff Machat, MD, Jod Mehta, MD, Minoru Tomita, MD, PhD

 

The next generation of femtosecond laser technology, the FEMTO LDV Z8 from Ziemer, was displayed to the public for the first time in October 2013 at the ESCRS in Amsterdam.

We asked four leading surgeons who regulary perform cataract and refractive surgery about the Z8, after they had a a chance to use it.


Tom Tooma, MD, USA

NVISION Laser Eye Centers is the first LASIK provider in California to offer the Z-LASIK Crystal Line technology, which offers faster healing time, fewer LASIK side effects such as dry eye, and more immediate results.

 


 

 



Scott M. MacRae, MD

In this video interview, Scott MacRae, MD, director of refractive surgery at the University of Rochester (USA), shares his clinical experience with the new FEMTO LDV Z6.

 


 

 


 

Minoru Tomita, MD, PhD

In this interview, Minoru Tomita, MD, PhD, executive director of the Shinagawa LASIK Center (Japan), shares his clinical experience with the new FEMTO LDV Z Models.

 

 


 

by Christian Rathjen, PhD, Frank Ziemer, Prof. Holger Lubatschowski

In this video, the Ziemer Group reviews its proprietary femtosecond technology and new FEMTO LDV Z Models. Interviews with Frank Ziemer, President and CEO of Ziemer Group, Christian Rathjen, PhD, Vice President of Technology and Strategy Ziemer Group, and Prof. Holger Lubatschowski, CEO of ROWIAK, reveal the key success factors for the company and the new systems – and tell about what the future may bring regarding femto-cataract technology.

 

 

     

Availability
The FEMTO LDV Z2, Z4, Z6 and Z8 are CE marked and FDA cleared. For some countries, availability may be restricted due to regulatory requirements; please contact Ziemer for details. Presbyopia treatments occur exclusively by a pocket creation and the implantation of a corresponding corneal inlay of a third party. Availability of related corneal inlays and implants may vary according to policy of the individual manufacturers and regulatory status in the individual countries. To comply with FDA regulations, devices for sale in the U. S. do not mention 'Presbyopia' on the panels.